Your browser version may not work well with NCBI's Web applications. More information here...
1: J Vet Med Sci. 1996 Aug;58(8):723-6.Links

Prognosis of malignant mammary tumor in 53 cats.

Ito T, Kadosawa T, Mochizuki M, Matsunaga S, Nishimura R, Sasaki N.

Department of Veterinary Surgery, Faculty of Agriculture, University of Tokyo, Japan.

Medical records of fifty-three cats diagnosed as malignant mammary tumor from 1982 to 1993 were reviewed. The mean age of the cats at diagnosis was 11.1 years, and Japanese domestic and Siamese breeds were predominant. Survival rates after 1 and 2 years of diagnosis were 31.8% and 17.7%, respectively, suggesting poor prognosis of this malignancy. The survival time was significantly associated with tumor size or WHO clinical stage, but not with breed, age, or gender. Twenty-nine cats with pulmonary metastasis died within 5 months following metastatic detection. Postoperative prognosis was significantly related to the tumor size at surgery, but not with type of surgery and adjuvant chemotherapy using cyclophosphamide and/or vincristine.

PMID: 8877968 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Cyclophosphamide (Cytoxan® , Neosar® )

    Your doctor has ordered the drug cyclophosphamide to help treat your illness. The drug can be taken by mouth in tablet form or be given by injection into a vein.

  • Vincristine (Oncovin® , Vincasar® )

    Your doctor has ordered the drug vincristine to help treat your illness. The drug is given by injection into a vein.

  • Source: AHFS Consumer Medication Information